SUAT TERZİ, Mehmet BİRİNCİ, Zerrin Özergin COŞKUN, ABDULKADİR ÖZGÜR, ENGİN DURSUN

Orofarengeal kanamanın nadir bir sebebi: Dil kökü yerleşimli Kaposi sarkomu

Kaposi Sarkomu, sıklıkla immün yetmezlikli hastalarda, vasküler endotelin ve bağ dokusunun proliferasyonu şeklinde gözüken, yavaş seyirli nadir bir malignitedir. En sık görünümü cilt lezyonları olsa da, atipik lokasyonlarda gö- rülebilmektedir. Abondan ağızdan kanama, dil kökünde polipoid kitle ile başvuran ve tetkikler sonucunda Kaposi Sarkomu tanısı alan bir olguyu sunduk.

A rare cause of oropharyngeal bleeding: Kaposis sarcoma located on the basis of tongue

Kaposi Sarcoma is a slowly progressing rare malign lesion, commonly presenting with proliferation of vascular endothelium and connective tissues in immune-compromised patients. Although the most common presentation is lesions of the skin, Kaposi Sarcoma may occur in atypical locations. We present a case presenting with abundant bleeding in the oral cavity, and polypoid mass at the basis of tongue, which was finally diagnosed as Kaposi Sarcoma.

PDF

___

Angouridakis N, Constantinidis J, Karkavelas G, et al. Classic (Mediterranean) Kaposis sarcoma of the true vocal cord: a case report and review of the literature. Eur Arch Otorhinolaryngol 2006;263:537-540.
Jindal JR, Campbell BH, Ward TO, et al. Kaposis sarcoma of the oral cavity in a non-AIDS patient: case report and review of the literature. Head Neck 1995;17:64-68.
Pantanowitz L, Dezube BJ. Kaposi sarcoma in unusual locations. BMC Cancer 2008;8:190.
Crosetti E, Succo G. Non-human immunodeficiency virusrelated Kaposis sarcoma of the oropharynx: a case report and review of the literature. J Med Case Rep 2013;7:293.
Teke F, Akkurt Z, Yıldırım, et al. Evaluation of 14 patients performed radiotherapy due to Kaposi sarcoma. Dicle Med J 2015;42:326-330.
Tur E, Brenner S. Classic Kaposis sarcoma: low-dose interferon alfa treatment. Dermatology 1998;197:37-42.
Campione E, Diluvio L, Paterno EJ, et al. Kaposis sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia. Clin Ther 2009;31:2565-2569.